Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 22, 2026Frontiers in ChemistryOpen Access

Active targeting towards bone cancer and metastases by pamidronate-bridged dinuclear platinum(II) complexes

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAnna Maria Di CosolaABAlessandra BarbanenteLDLuisa D’Anna

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cosola et al. (2026) studied this question.

synapsesocial.com/papers/6ab71c2e88223941828ed4e9https://doi.org/10.3389/fchem.2026.1945537
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring Selenium-Functionalized Hydroxyapatite Using Organic Selenocystine for Antitumor Applications2025 · 2 citations
  2. 2New oxaliplatin-zoledronate derivatives with potential antitumor activity towards bone tumors and metastases2025 · 5 citations
  3. 3Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy2026
  4. 4Bisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG-63 human osteosarcoma cells2012 · 35 citations
  5. 5Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients2016 · 29 citations